Cerebri Biofeedback Feasibility Trial

Exclusion Criteria

• •Having a continuous background headache that never disappears completely.
• •More than 14 days of headache (all types) per 28-day period.
• •Subjects diagnosed with trigeminal autonomic cephalalgias and neuralgias.
• •Subjects with secondary headache conditions.
• •Subjects with headaches attributed by the treating neurologist/physician as being medication overuse headache according to the ICHD-3.
• •Subject with pathologies that inhibit use of the device according to the instructions for use (e.g., blindness, deafness).
• •Use of any concurrent preventive treatment (medications, meditation, physical therapy and psychotherapy as a headache treatment, acupuncture, etc.).
• •Subjects who have previously failed three prophylactic pharmacological treatments.
• •Subjects taking opioids (\>3 days per month) or barbiturates at the time of screening.
• •Subject participates in another clinical investigation.
• •Alcohol overuse according to ICD-10-CM Code F10.1 or illicit drug use.
• •Subject who is unlikely to follow Clinical Investigation Plan or where treatment seems futile in the opinion of the Investigator or have demonstrated an inability to sufficiently adhere to headache diary entries (\<80%).